← SynDRA
AZITHROMYCIN
SynDRA canonical compound SYN0000651 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | MLNR |
| Mechanism of action | bacterial 50S ribosomal subunit inhibitor |
| Indication | pelvic inflammatory disease | pneumonia |
| Disease area | infectious disease |
All known targets
- MLNR
- ABCB1
- ABCC2
- KCNH2
- TAS2R4
Mechanisms of action (all sources)
- bacterial 50S ribosomal subunit inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- GHSR
- NPY2R
- NPY1R
- MT-CO1
- MMP9
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LMNA
- LCK
- IDH1
- HTR7
- HTR6
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- HTR1A
- HRH3
- HRH2
- HRH1
- HMGCR
- HDAC6
- GMNN
- GLP1R
- NR3C1
- NTSR1
- OPRD1
- SAMHD1
- TSHR
- TDP1
- TBXAS1
- TBXA2R
- TARDBP
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Macrolide Antimicrobial
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01F · MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
- S01A · ANTIINFECTIVES
- COMBINATIONS OF ANTIBACTERIALS
Cross-references
Synonyms
- AZASITE
- AzaSite
- TROVAN/ZITHROMAX COMPLIANCE PAK
- ZITHROMAX
- ZMAX
- Zithromax
- CP 62993
- arzomicin
- aziromycin
- Azithromycin A
- azithromycin monohydrate
- azithromycin anhydrous
- azithromycin dihydrate
- azithromycin hydrate
- Azithromycin dihydrate
- Azithromycine
- Azitromicina
- Azithromycin hydrate
- Anhydrous azithromycin
- Aruzilina
- Aziromycin
- Azithrocin
- Azithromycin (as dihydrate)
- Azithromycin anhydrous
- Azithromycin, unspecified
- Azithromycin, unspecified form
- Aziwin
- Durasite
- Hemomycin
- Macrozit
- Sumamed
- Trozocina
- Xithrone
- Zithromac
- Zythromax
- CP-62993
- CP-62,993
Reported adverse events
- Asthenia
- Arrhythmia
- Dyspepsia
- Arthralgia
- Thrombocytopenia
- Dizziness
- Fatigue
- Hepatotoxicity
- Palpitations
- Headache
- Rash
- Hypersensitivity
Look up AZITHROMYCIN in the interactive SynDRA portal →